Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%

Bulletin Express06-30

Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed that it bought back 95,200 H shares on 30 June 2026 through the Hong Kong Stock Exchange.

The shares were repurchased at prices between HKD 17.38 and HKD 17.81, translating into an average consideration of HKD 17.713 per share and an aggregate outlay of HKD 1.69 million. All repurchased shares are being held as treasury stock.

Following the transaction, Bao Pharma’s issued share capital (excluding treasury shares) declined to 154.23 million from 154.33 million, representing a 0.06% reduction. Treasury shares now stand at 95,200.

The buyback forms part of a mandate approved by shareholders on 26 May 2026, which authorises the repurchase of up to 15.43 million shares. To date, 0.06% of this limit has been utilised. Under Hong Kong listing rules, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119988416?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 19:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119988416","market":"hk","top_or_hot":-1,"title":"Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%","media":"Bulletin Express","content":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed that it bought back 95,200 H shares on 30 June 2026 through the Hong Kong Stock Exchange.</p>\n<p>The shares were repurchased at prices between HKD 17.38 and HKD 17.81, translating into an average consideration of HKD 17.713 per share and an aggregate outlay of HKD 1.69 million. All repurchased shares are being held as treasury stock.</p>\n<p>Following the transaction, Bao Pharma’s issued share capital (excluding treasury shares) declined to 154.23 million from 154.33 million, representing a 0.06% reduction. Treasury shares now stand at 95,200.</p>\n<p>The buyback forms part of a mandate approved by shareholders on 26 May 2026, which authorises the repurchase of up to 15.43 million shares. To date, 0.06% of this limit has been utilised. Under Hong Kong listing rules, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBao Pharma repurchases 95,200 H shares for HKD 1.69 million; outstanding share count falls 0.06%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-30 19:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed that it bought back 95,200 H shares on 30 June 2026 through the Hong Kong Stock Exchange.</p>\n<p>The shares were repurchased at prices between HKD 17.38 and HKD 17.81, translating into an average consideration of HKD 17.713 per share and an aggregate outlay of HKD 1.69 million. All repurchased shares are being held as treasury stock.</p>\n<p>Following the transaction, Bao Pharma’s issued share capital (excluding treasury shares) declined to 154.23 million from 154.33 million, representing a 0.06% reduction. Treasury shares now stand at 95,200.</p>\n<p>The buyback forms part of a mandate approved by shareholders on 26 May 2026, which authorises the repurchase of up to 15.43 million shares. To date, 0.06% of this limit has been utilised. Under Hong Kong listing rules, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1119988416","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119988416","pubTimestamp":1782817473,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed that it bought back 95,200 H shares on 30 June 2026 through the Hong Kong Stock Exchange. The shares were repurchased at prices between...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"宝药业169万港元回购9.52万股H股；流通股数量下降0.06%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed that it bought back 95,200 H shares on 30 June 2026 through the Hong Kong Stock Exchange.\nThe shares were repurchased at prices between HKD 17.38 and HKD 17.81, translating into an average consideration of HKD 17.713 per share and an aggregate outlay of HKD 1.69 million. All repurchased shares are being held as treasury stock.\nFollowing the transaction, Bao Pharma’s issued share capital (excluding treasury shares) declined to 154.23 million from 154.33 million, representing a 0.06% reduction. Treasury shares now stand at 95,200.\nThe buyback forms part of a mandate approved by shareholders on 26 May 2026, which authorises the repurchase of up to 15.43 million shares. To date, 0.06% of this limit has been utilised. Under Hong Kong listing rules, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119988416","isCrawlerRequest":true}